The QMB Innovation Centre
As QMB continues to expand its offering, so does our reputation amongst some of the best known names inside the bioscience community
“The conspicuous success of the QMB Investment forum shows that innovation is flourishing in the life sciences sector. For larger venture capital investors life SVLS, we aim to fund the clinical development of novel products and technologies, that come from thriving university labs such as QMB, so we welcome the energy and success of QMB.”
Kate Bingham, Managing Partner at Schroder Ventures Life Sciences
“Investment Forum was a thoroughly enjoyable day. The organisers got the balance just right with the facilities at the QMB Innovation Centre looking absolutely World Class. As a bio-entrepreneur who has recently raised £8 million for KalVista, I was in the nice position of not having to pitch at this event, but I came out feeling energised and motivated to dust off my plans and start thinking about forming another biotech company. ”
Robert Haigh, COO at Kalvista
"The team has spent several years working in academic surroundings and we are extremely excited to move into the Innovation Centre. It marks a real milestone in terms of commercial development of the Company and QMB, being so close to the City and with such excellent facilities seemed the ideal choice for us. We have state of the art laboratories for our research as well as space for growth and support in developing the business – vital for early stage companies."
Professor Peter Vanezis OBE, the Head of the Scientific Advisory Board of iGene.
“I thought the QMB Investment Forum was well organised, very professional and you showcased a great set of sensible investment opportunities. We look forward to working with QMB at other successful events going forward."
Kaasim Mahmood, Partner at Advent Venture Partners
"One unique feature of QMB is its proximity to world-class medical research in the Blizard building next door, and the new hospital in Whitechapel-the biggest hospital build in Europe and the largest NHS trust in the UK.
Tenants at the QMB Innovation Centre are welcome to join in the full academic life of the medical and dental school.
As the medical schools research is now partly judged by impact, the spin outs from the medical school into QMB, and the synergies between our research and that of tenants in QMB; can only enhance this agenda"
Professor Thomas T. MacDonald PhD FRCPath FMedSciDean for Research, Barts and The London School of Medicine and Dentistry
“This new facility will allow Retroscreen to further enhance its Human Viral Challenge Model capability with dedicated en suite isolation rooms, on site laboratory support and integrated data management. This is the first clinical facility dedicated to Human Viral Challenge Studies since the closure of the Common Cold Institute in the 1990s. As a specialist virology contract research organisation (CRO), Retroscreen is the only company to offer Human Viral Challenge Studies in influenza, respiratory syncytial virus (RSV) and the common cold.”
Dr Robert Lambkin-Williams, CSO at Retroscreen Virology
"The inaugural QMB Investment Forum was a great new networking opportunity with a good mix of panel discussions, presentations and company pitches. I look forward to future participation and watching it develop from year to year - I'm sure it will go from strength to strength."
Andy Hill, CEO at Intelligent Ultrasound
“Duvas Technologies is delighted to be moving its operations to the state-of-the-art facilities at the QMB Innovation Centre. We believe that the facilities on offer, and the location of QMB very close to the City of London, will offer a great platform for Duvas as it moves into its next stage of commercial development.”
Jacqui Nelson, CEO at Duvas
"We received lots of interest from the QMB event. The quality of investors was extremely high and the company is already in discussions with investors from the event with whom it can close this round."
Toby Wilson Waterworth, CEO at Atlantic Healthcare
"The QMB Innovation Centre has been a pivotal ally. They provide strategic guidance, access to investors, mentors, and a ready-made network of contacts, specialised training, affordable space, and professional services at reduced rates, being inside the QMB incubator makes us realise that we not alone. Thank you!"
George Palikaras, Founder and CEO at MediWise
"The QMB Investment Forum was one of Aqix Limited’s most productive presentations of our novel patented therapy for Acute Kidney Injury. We have since the event received immediate investment interest from highly qualified investors on the day, and have ongoing negotiations as a result. Aqix are also still receiving new interest some weeks later. “
Matt Durdy, CEO at Aqix
The QMB Investment Forum was a useful and well managed event that has resulted in positive feedback for Orthox. We will continue to keep contact with QMB and look forward to attending their flourishing network of events
Nick Skaer, PhD.CEO, Orthox Ltd.
We were delighted to be involved in the inaugural QMB Investment forum. The delegate list was of a high quality and so the networking opportunities were terrific and it was very well organised from start to finish.
Frances P. Doherty, Partner at Dorsey & Whitney LLP